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Aspergillus Nidulans: A Rare Etiological Agent of Eumyce-
toma
B. Mehta ∗, R. Pereira, S. Savant, C. Nayak, S. Amladi, S.
Deshpande
B.Y.L. Nair Charitable Hospital and T.N. Medical College,
Mumbai, India
Mycetomas caused by true fungi are known as eumyce-
tomas. Common causative species are Madurella, Lep-
tosphaeria, Aspergillus, Exophiala, Fusarium, Acremonium,
and Scedosporium. Aspergillus nidulans is a rare etiologi-
cal agent, causing pale grain mycetoma. Only 7 cases of
Aspergillus nidulans mycetoma have been reported in lit-
erature - 1 from India (Rajasthan, 1985), 6 from Africa.
We report this case of mycetoma because of the rarity
of Aspergillus nidulans as an etiological agent. A 41 year
old male shopkeeper presented with multiple painful nod-
ules and discharging sinuses on the right upper extremity
since 12 years. The affected limb was swollen and woody
hard. There was a single enlarged (3 cm) ﬁrm, non-tender
right axillary lymph node. There was no fever or other con-
stitutional symptoms. The initial nodule had appeared on
the distal right forearm 12 years earlier without preceding
trauma. Gradually similar lesions had appeared extending up
to the upper arm, breaking down discharging seropurulent
material without grains. He had been treated empirically
with oral antibiotics and had undergone surgical drainage
of the nodules, with temporary relief. Right sided axillary
lymph node dissection had been performed 10 years ago;
however no organism had been detected. Routine blood
investigations were normal. X-ray of the involved extrem-
ity showed soft tissue swelling without evidence of bony
involvement. Histopathology from a recent discharging nod-
ule showed a mixed inﬂammatory inﬁltrate of mononuclear
cells, neutrophils, plasma cells and eosinophils along with
marked thickening and ﬁbrotic changes in the dermis. Cul-
ture from the nodules repeatedly grew Aspergillus nidulans.
The patient is currently under treatment with itraconazole
and potassium iodide since 1 month and, is responding well.
doi:10.1016/j.ijid.2008.05.757
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Zanthoxylum xanthoxyloides products are commonly
used as spices in local food and for traditional treatment of
many infections in Cameroon. The crude ethanolic extracts
and some hexanic/chloroformic and chloroformic fractions
from the roots and stem bark of Z. Xanthoxyloides were
tested for antifungal activity against Microsporum gypseum,
Trichophyton mentagrophytes, Trichophyton rubrum, Can-
dida albicans and Cryptococcus neoformans using the broth
microdilution method. Both plant extracts were also inves-
tigated for their acute toxicity on mice using the WHO
experimental protocol. The extracts and tested fractions
showed fungicidal effects against the three dermatophytes
and C. neoformans with minimal fungicidal concentrations
(MFCs) ranging from 250 to 1000g/ml and from 25 to
100g/ml respectively. Both extracts and only fractions
from the stem bark exhibited fungistatic activity against
C. albicans. Dermatophytes showed to be the most sus-
ceptible than yeasts. The acute toxicity orally evaluated in
mice, was found to be very low toxic. From roots and stem
bark extracts LD50 are respectively 13.2 and 5.8 g/kg for
male and 10.4 and 7.4 g/kg body weight for female. Female
mice showed a different behaviour compared to those male
and their body weight evolution was statistically signiﬁca-
tive (p < 0.05) with the stem bark extract. The results of
the fungicidal activity screening support the ethnomedici-
nal uses of the plant to some extent. These results suggest
also a carefully use of the plant in folk medicine.
doi:10.1016/j.ijid.2008.05.758
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Continuous Infusion of Amphotericin B deoxycholate
in the Treatment of Cryptococcal Meningoencephalitis:
Analysis of Safety and Fungicidal Activity
D.R. Falci ∗, C.G. Ramos, V.R. Aquino, L.Z. Goldani
Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
Background: Cryptococcosis is a deep mycosis commonly
seen in immunocompromised hosts, including HIV/AIDS
patients. The mainstay of treatment remains amphotericin
B deoxycholate, which is associated with nephrotoxicity and
infusion-related reactions, along with other side effects.
New lipid formulations provide a good solution to toxicity
concerns. Reduction in nephrotoxicity and side effects can
be explained by slower drug distribution in tissues. However,
costs of these formulations are prohibitive. In this sce-
nario, continuous infusion of amphotericin B deoxycholate
for the treatment of fungal infections like cryptococcosis
could be a promisable strategy. Our objective in this study
is to evaluate safety, clinical and microbiological efﬁcacy
of continuous infusion of amphotericin B deoxycholate in
treatment of cryptococcal meningoencephalitis.
Methods: Non-comparative clinical trial, including
patients with disseminated cryptococcosis and AIDS. All
patients received continuous infusion of amphotericin
B deoxycholate (0.7mg/kg daily) and oral ﬂucytosine
(25mg/kg four times a day), during induction phase of 14
days. We measured fungicidal activity using serial quanti-
tative cultures of cerebrospinal ﬂuid (CSF) obtained from
lumbar punctures in days 3, 7 and 14 of treatment. We mon-
itored patients in hospital for 2 weeks. At this time of study,
4(four) patients have been included.
Results: Preliminary data on 4 patients have shown that
all patients presented a progressive reduction in CSF crypto-
coccal colony-forming units(CFU), and LCR was sterile at 2
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weeks of treatment. An exponential reduction of CFU counts
was observed. Although two patients developed severe
hypokalemia, glomerular renal function was well preserved
in all patients with creatinine serum levels below 1.5mg/dl
at end of 14 days of antifungal therapy.
Conclusion: Continuous infusion of amphotericin B seems
to be safe and well tolerated. Mycological efﬁcacy was com-
parable as standard of treatment, with adequate reduction
rate of CFU and sterilization of CSF. These data could suggest
that continuous infusion reduces nephrotoxicity while keep-
ing fungicidal activity. Larger and comparative trials, against
new lipid formulations and even novel antifungal agents, are
necessary to further evaluate this treatment regimen.
doi:10.1016/j.ijid.2008.05.759
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Introduction: The incidence of invasive fungal infections
is increasing worldwide and rare fungi - neither belonging to
the genera Aspergillus, Candida, Pneumocystis or Crypto-
coccus, nor being endemic or regional, such as Histoplasma
spp. or Coccidioides spp. - are increasingly identiﬁed as
causative pathogens. Reliable, evidence based treatment
recommendations for these species have not been estab-
lished, yet.
Methods: We are coordinating a global registry for cases
of rare invasive fungi. Our objective is to broaden the knowl-
edge on epidemiology, to determine the clinical pattern
of disease, to describe and improve diagnostic proce-
dures and therapeutic regimens, as well as to to facilitate
exchange of clinical isolates among the contributors. Entry
of retrospective data occurs via a web-based registration
system (MACRO) that focuses on demographic information,
underlying diseases, risk factors, details on the infection
(pathogen, localization, specimen collection) therapy and
outcome. Inclusion criteria include cultural, histopatholog-
ical, antigen, or DNA evidence of invasive fungal infection.
Infection due to Aspergillus spp., Candida spp., Crypto-
coccus neoformans, Pneumocystis jiroveci or any endemic
fungal infection, such as coccidioidomycosis or histoplasmo-
sis, as well as colonisation or other non-invasive infection
are exclusion criteria.
Results: By now, 28 cases of rare mycoses have been
identiﬁed, including Absidia corymbifera, Cunninghamella
bertholletiae, Penicillium marneffei, Rhizomucor pusillus,
as well as Acremonium spp., Fusarium spp., Coccidioides
spp., and Trichoderma spp. Clinical results are partly pend-
ing. Most patients were in an immunocompromised state as
a result of their underlying disease, chemotherapy or trans-
plantation.
Discussion: The clinical relevance of invasive fungal
infections by rare fungi is increasing steadily. In a short
period of time, actual cases from Germany, Austria, Italy
and the United Kingdom could be documented, showing
the broad spectrum of pathogens. Further investigators and
coordinators are cordially invited to contribute to the suc-
cess of Fungiscope!
doi:10.1016/j.ijid.2008.05.760
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Aspergillus fumigatus is an opportunistic and one of the
most ubiquitous of the airborne saprophytic fungi which
causes a number of life threatening diseases in humans
and animals. Invasive aspergillosis which occurs in a wide
range of clinical scenarios is protean in its manifestations,
and is still associated with an unacceptably high mor-
tality rate. People most at risk for aspergillosis include
patients with advanced AIDS, prolonged neutropenia, allo-
geneic hematopoietic stem cell transplant recipients, solid
organ transplant recipients, and chronic granulomatous dis-
ease. The difﬁculties of early diagnosis and treatment of
fungal infections has given rise to high mortality rate.
Indeed, these infections are all too frequently diagnosed
at an advanced stage and prone to rapid progression. In
fact, the vital signiﬁcance of early and accurate diagnosis
of Aspergillus infections and the substantiated pathogenic
has been the main reason behind the current study. In this
regard the production and partial characterization of eleven
monoclonal antibodies (MAbs) directed against the cell wall
antigens of Aspergillus fumigatus in immunized BALB/c mice
is described. Three IgM and eight IgG monoclonal antibod-
ies were produced. Two IgG MAbs were chosen to large
scale production and puriﬁcation. They did not show any
cross-reactivity with other pathogenic species of Aspergillus
and Candida. The above antibodies displayed a substantial
amount of sensitivity and speciﬁcity. Also, they proved to
be effective in detecting Aspergillus fumigatus antigens in
lung and kidney tissues of mice infected with Aspergillus
fumigatus.
doi:10.1016/j.ijid.2008.05.761
